Movano Inc., a technology company focused on developing healthcare solutions, reported its financial results for the second quarter of 2025, revealing a revenue of $103,000, a significant increase from zero revenue in the same quarter of 2024. For the first half of 2025, the company generated $309,000 in revenue, down 64% from $852,000 in the first half of 2024. The decline in revenue is attributed to reduced marketing efforts, which led to lower sales volume of its Evie Ring product, a wearable health device launched in late 2023.
The company's total operating expenses for the second quarter of 2025 were $3.4 million, a decrease of 47% compared to $6.4 million in the same quarter of 2024. This reduction was primarily driven by lower research and development costs, which fell by 52% to $1.4 million, and a 49% decrease in sales, general, and administrative expenses, which totaled $1.6 million. As a result, Movano's loss from operations improved to $3.3 million in the second quarter of 2025, compared to a loss of $6.4 million in the same period last year.
Movano's accumulated deficit reached $156.5 million as of June 30, 2025, reflecting ongoing challenges in achieving profitability. The company reported a net loss of $3.2 million for the second quarter, an improvement from a net loss of $6.2 million in the same quarter of 2024. The weighted average shares used in calculating net loss per share increased to 7.8 million, resulting in a net loss per share of $0.41, compared to $0.93 in the prior year.
Operationally, Movano has been focusing on the development of its Evie Ring and EvieMED Ring, the latter of which received FDA clearance for its pulse oximetry feature. The company is also working on a proprietary System-on-a-Chip (SoC) designed for blood pressure and continuous glucose monitoring. As of June 30, 2025, Movano had $2.1 million in cash and cash equivalents, a decrease from $7.9 million at the end of 2024, and it anticipates needing additional financing to support its operations beyond 2025.
Looking ahead, Movano's management has initiated a process to explore strategic alternatives to maximize shareholder value, engaging financial and legal advisors to assist in this endeavor. The company acknowledges the need for further capital to continue its operations and is considering various financing options, including equity offerings and strategic partnerships. However, there is substantial doubt about the company's ability to continue as a going concern if it cannot secure the necessary funding.
About Movano Inc.
Movano Inc. develops wearable health devices focused on women’s wellness and chronic disease management. Its products, including the Evie Ring and EvieMED Ring, provide medical-grade data on vital signs, blood oxygen, and menstrual health. The company aims to deliver non-invasive, continuous monitoring solutions for conditions like diabetes and hypertension, combining proprietary RF technology with consumer-friendly design to enhance preventative care and clinical applications.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.